Thomas Pugh, MD
Radiation Oncology · Denver, CONPI 1174679799
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,172 of the $14,785 with a category attached, or 82.3%. Boston Scientific accounts for 97.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $8,938 and has fallen 99.7% since, to $23 in 2025. Among radiation oncology clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $328.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$14K
- Myovant Sciences Inc.$93
- Telix Pharmaceuticals$91
- Astellas Pharma US Inc$86
- Sumitomo Pharma America, Inc.$53
- Siemens Medical Solutions USA, Inc.$42
- plus $81 from 4 others
Across 39 payments — averaging $2624.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$102K
What the payments were for
- Consulting fees$1,63511%
- Speaking & faculty fees$12,17282%
- Food & beverage$9797%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 24 | $14,339 |
| Myovant Sciences Inc. | 5 | $93 |
| Telix Pharmaceuticals | 5 | $91 |
| Astellas Pharma US Inc | 4 | $86 |
| Sumitomo Pharma America, Inc. | 2 | $53 |
| Siemens Medical Solutions USA, Inc. | 1 | $42 |
| 180 Medical, Inc. | 1 | $27 |
| Pfizer | 1 | $20 |
| Bayer | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SpaceOAR VUE System - 10mL$13,806
How this compares
$14,785 in reported general payments places this provider in the 90th percentile of 105 radiation oncology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 213 | $2,659 |
| Methylprednisolone | 99 | $642 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Denver
- Seth ReinerDenver$2K
- Christopher DeigDenver$2K
- Eugene ChungDenver$1K
- Mark ChidelDenver$1K
- Ari BallonoffDenver$375
- Andrzej WojcieszynskiDenver$369
- Peter RossiGlenwood Springs$146K
- Suraj SinghGreely$134K
- Meera PatelAurora$112K
- David RabenAurora$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.